NextFin

Pfizer (PFE) Drops 1.04% to Close at $26.58 Amid Active Trading

Summarized by NextFin AI
  • On March 13, 2026, Pfizer Inc. (PFE) opened at $27.02 but closed at $26.58, marking a decrease of $0.28 or -1.04%.
  • The stock fluctuated between a daily high of $27.28 and a low of $26.58, with a trading volume of approximately 34.25 million shares.
  • The total market capitalization of Pfizer was around $151.14 billion, indicating significant investor activity.
  • Market conditions, regulatory news, and sector dynamics likely influenced Pfizer's stock performance on this day.

Pfizer Inc. (Ticker: PFE) Market Performance Summary for March 13, 2026

On March 13, 2026, Pfizer Inc. (PFE) experienced a notable trading session in the U.S. stock market. The stock opened at $27.02, reflecting a slight increase from its previous closing price of $26.86. However, throughout the day, the stock faced downward pressure, ultimately closing at $26.58. This marked a decrease of $0.28, which translates to a percentage change of -1.04%.

Key Market Metrics:

  • Opening Price: $27.02
  • Closing Price: $26.58
  • Daily High: $27.28
  • Daily Low: $26.58
  • Volume: Approximately 34.25 million shares traded
  • Previous Close: $26.86
  • Change: -$0.28
  • Percentage Change: -1.04%
  • Total Market Capitalization: Approximately $151.14 billion

Market Context:

The trading range for the day was relatively tight, with the stock fluctuating between a high of $27.28 and a low of $26.58. The overall trading volume was substantial, indicating a high level of activity and interest among investors. The total volume of shares traded was approximately 34.25 million, contributing to a total market value of around $151.14 billion.

Pfizer's stock performance on this day can be analyzed against broader market trends and sector-specific developments. While specific news articles or significant announcements directly impacting Pfizer were not available, the pharmaceutical sector as a whole often reacts to various external factors, including regulatory news, earnings reports from competitors, and changes in healthcare policies.

The recent performance of Pfizer may also be influenced by investor sentiment regarding the pharmaceutical industry, particularly in light of ongoing developments related to drug approvals, clinical trial results, and market competition. Additionally, macroeconomic factors such as interest rates, inflation data, and overall market volatility can play a crucial role in shaping investor behavior and stock price movements.

Conclusion:

In summary, Pfizer Inc. faced a challenging trading session on March 13, 2026, with a closing price of $26.58, reflecting a decrease of 1.04% from the previous day. The stock's performance was characterized by a daily high of $27.28 and a low of $26.58, with significant trading volume indicating active investor participation. While no specific news was reported on this date to directly influence the stock, ongoing market conditions and sector dynamics likely contributed to the observed price movements. Investors will continue to monitor Pfizer for any forthcoming announcements or developments that may impact its stock performance in the future.

Explore more exclusive insights at nextfin.ai.

Insights

What are the key factors influencing Pfizer's stock performance?

How has Pfizer's market capitalization changed over recent years?

What historical events have significantly impacted Pfizer's stock price?

What trends are currently shaping the pharmaceutical industry?

How do regulatory changes affect Pfizer's operations?

What were the major competitors to Pfizer in 2026?

What recent news has affected investor sentiment towards Pfizer?

What are the potential long-term impacts of current healthcare policies on Pfizer?

What challenges does Pfizer face in maintaining its market position?

How does Pfizer's trading volume compare to its competitors?

What are the implications of interest rates on Pfizer's stock price?

What strategies could Pfizer employ to improve its stock performance?

How do macroeconomic factors influence Pfizer's market performance?

What are the investor reactions to Pfizer's recent stock fluctuations?

What role do clinical trial results play in Pfizer's market value?

How does Pfizer's stock performance reflect broader market conditions?

What insights can be drawn from Pfizer's daily price movements?

What are the implications of Pfizer's stock decline on investor confidence?

What are the most significant risks facing Pfizer's stock in the near future?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App